Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - PSS WORLD MEDICAL INC | d8k.htm |
| EX-99.1 - PRESS RELEASE - PSS WORLD MEDICAL INC | dex991.htm |
Exhibit 99.2
Financial Supplement
For the Second Quarter of Fiscal Year 2010 ending October 2, 2009
PSS World Medical, Inc.
As of October 2, 2009
Current Fiscal Year
(in thousands, except per share data)
| Fiscal 2010 | ||||||||
| Q1 | Q2 | |||||||
| Net sales |
$ | 493,554 | $ | 561,976 | ||||
| Cost of goods sold |
347,581 | 389,404 | ||||||
| Gross profit |
145,974 | 172,571 | ||||||
| General & administrative expenses |
91,638 | 97,208 | ||||||
| Selling expenses |
32,687 | 36,728 | ||||||
| Income from operations |
21,649 | 38,635 | ||||||
| Interest expense |
(4,261 | ) | (4,532 | ) | ||||
| Interest & investment income |
134 | 95 | ||||||
| Other income |
3,995 | 452 | ||||||
| Income from ops before income taxes |
21,517 | 34,650 | ||||||
| Provision for income taxes |
8,213 | 12,964 | ||||||
| Net income |
$ | 13,304 | $ | 21,686 | ||||
| Earnings per share - basic: |
||||||||
| Net income |
$ | 0.23 | $ | 0.37 | ||||
| Earnings per share - Diluted: |
||||||||
| Net income |
$ | 0.23 | $ | 0.37 | ||||
| WASO - Basic |
58,380 | 58,566 | ||||||
| WASO - Diluted |
58,859 | 59,390 | ||||||
| Net sales by segment: |
||||||||
| Physician Business |
$ | 342,292 | $ | 398,531 | ||||
| Elder Care Business |
150,381 | 162,970 | ||||||
| Corporate Shared Services |
882 | 475 | ||||||
| $ | 493,554 | $ | 561,976 | |||||
| Billing days: |
64 | 68 | ||||||
| Net sales per billing day: |
||||||||
| Physician Business |
$ | 5,348 | $ | 5,861 | ||||
| Elder Care Business |
2,350 | 2,397 | ||||||
| Corporate Shared Services |
14 | 7 | ||||||
| $ | 7,712 | $ | 8,264 | |||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
As of October 2, 2009
(in thousands, except per share data)
|
Fiscal 2007 |
Fiscal 2008 | Fiscal 2009 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Q1 |
Q2 | Q3 | Q4 | Total | Q1 | Q2 | Q3 | Q4 | Total | Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales |
$ | 413,135 | $ | 427,059 | $ | 458,421 | $ | 443,024 | $ | 1,741,639 | $ | 438,910 | $ | 457,930 | $ | 465,208 | $ | 493,744 | $ | 1,855,791 | $ | 472,215 | $ | 491,603 | $ | 519,145 | $ | 469,728 | $ | 1,952,691 | ||||||||||||||||||||||||||||||
| Cost of Goods Sold |
293,233 | 303,204 | 335,185 | 310,008 | 1,241,629 | 311,227 | 325,390 | 330,215 | 347,289 | 1,314,120 | 333,283 | 344,347 | 364,282 | 328,868 | 1,370,781 | |||||||||||||||||||||||||||||||||||||||||||||
| Gross Profit |
119,902 | 123,856 | 123,235 | 133,017 | 500,010 | 127,683 | 132,540 | 134,993 | 146,455 | 541,672 | 138,931 | 147,255 | 154,863 | 140,860 | 581,910 | |||||||||||||||||||||||||||||||||||||||||||||
| General & Administrative Expenses |
73,695 | 73,422 | 75,253 | 78,453 | 300,824 | 83,638 | 77,353 | 79,408 | 83,725 | 324,124 | 89,634 | 90,689 | 89,426 | 82,728 | 352,478 | |||||||||||||||||||||||||||||||||||||||||||||
| Selling Expenses |
27,498 | 28,878 | 30,140 | 30,308 | 116,823 | 29,551 | 30,763 | 31,509 | 33,473 | 125,295 | 31,266 | 32,161 | 33,721 | 31,356 | 128,505 | |||||||||||||||||||||||||||||||||||||||||||||
| Income from operations |
18,709 | 21,556 | 17,842 | 24,255 | 82,362 | 14,494 | 24,425 | 24,077 | 29,257 | 92,253 | 18,031 | 24,405 | 31,715 | 26,776 | 100,927 | |||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
(2,691 | ) | (2,635 | ) | (2,642 | ) | (2,631 | ) | (10,597 | ) | (2,764 | ) | (2,956 | ) | (3,247 | ) | (3,529 | ) | (12,495 | ) | (3,203 | ) | (5,300 | ) | (7,409 | ) | (6,247 | ) | (22,159 | ) | ||||||||||||||||||||||||||||||
| Interest & Investment Income |
98 | 282 | 426 | 385 | 1,191 | 528 | 114 | 26 | 23 | 691 | 122 | 842 | 1,034 | 305 | 2,304 | |||||||||||||||||||||||||||||||||||||||||||||
| Other Income |
469 | 429 | 517 | 591 | 2,006 | 544 | 546 | 833 | 5,361 | 7,284 | 608 | 520 | 877 | 638 | 2,643 | |||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing Operations before Income Taxes |
16,588 | 19,632 | 16,144 | 22,601 | 74,965 | 12,802 | 22,129 | 21,690 | 31,112 | 87,732 | 15,559 | 20,467 | 26,218 | 21,472 | 83,716 | |||||||||||||||||||||||||||||||||||||||||||||
| Provision for Income Taxes |
6,449 | 7,681 | 5,862 | 7,824 | 27,817 | 5,010 | 8,551 | 8,441 | 12,597 | 34,599 | 6,187 | 8,104 | 10,230 | 7,709 | 32,229 | |||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing Operations |
10,139 | 11,951 | 10,282 | 14,777 | 47,148 | 7,792 | 13,578 | 13,249 | 18,515 | 53,133 | 9,372 | 12,363 | 15,989 | 13,763 | 51,486 | |||||||||||||||||||||||||||||||||||||||||||||
| Net Income |
$ | 10,137 | $ | 11,951 | $ | 10,282 | $ | 14,777 | $ | 47,146 | $ | 7,792 | $ | 13,578 | $ | 13,249 | $ | 18,515 | $ | 53,133 | $ | 9,372 | $ | 12,363 | $ | 15,989 | $ | 13,763 | $ | 51,486 | ||||||||||||||||||||||||||||||
| Earnings per share - Basic: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing Operations |
$ | 0.15 | $ | 0.18 | $ | 0.15 | $ | 0.22 | $ | 0.70 | $ | 0.12 | $ | 0.21 | $ | 0.21 | $ | 0.30 | $ | 0.82 | $ | 0.15 | $ | 0.21 | $ | 0.27 | $ | 0.23 | $ | 0.86 | ||||||||||||||||||||||||||||||
| Net Income |
$ | 0.15 | $ | 0.18 | $ | 0.15 | $ | 0.22 | $ | 0.70 | $ | 0.12 | $ | 0.21 | $ | 0.21 | $ | 0.30 | $ | 0.82 | $ | 0.15 | $ | 0.21 | $ | 0.27 | $ | 0.23 | $ | 0.86 | ||||||||||||||||||||||||||||||
| Earnings per share - Diluted: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing Operations |
$ | 0.15 | $ | 0.17 | $ | 0.15 | $ | 0.21 | $ | 0.68 | $ | 0.11 | $ | 0.20 | $ | 0.20 | $ | 0.29 | $ | 0.80 | $ | 0.15 | $ | 0.20 | $ | 0.27 | $ | 0.23 | $ | 0.85 | ||||||||||||||||||||||||||||||
| Net Income |
$ | 0.15 | $ | 0.17 | $ | 0.15 | $ | 0.21 | $ | 0.68 | $ | 0.11 | $ | 0.20 | $ | 0.20 | $ | 0.29 | $ | 0.80 | $ | 0.15 | $ | 0.20 | $ | 0.27 | $ | 0.23 | $ | 0.85 | ||||||||||||||||||||||||||||||
| WASO - Basic |
67,310 | 67,453 | 67,054 | 67,059 | 67,219 | 66,793 | 65,806 | 63,999 | 62,213 | 64,703 | 61,003 | 59,941 | 59,481 | 59,307 | 59,937 | |||||||||||||||||||||||||||||||||||||||||||||
| WASO - Diluted |
68,947 | 69,478 | 69,458 | 69,419 | 69,325 | 68,765 | 67,067 | 65,756 | 63,152 | 66,184 | 61,723 | 60,921 | 60,322 | 59,801 | 60,696 | |||||||||||||||||||||||||||||||||||||||||||||
| Net Sales by Segment: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Physician Business |
$ | 284,438 | $ | 300,813 | $ | 329,159 | $ | 313,109 | $ | 1,227,520 | $ | 306,245 | $ | 320,171 | $ | 326,520 | $ | 355,749 | $ | 1,308,685 | $ | 331,386 | $ | 341,761 | $ | 357,269 | $ | 326,966 | $ | 1,357,382 | ||||||||||||||||||||||||||||||
| Elder Care Business |
128,696 | 126,246 | 129,261 | 129,915 | 514,118 | 132,664 | 137,759 | 138,688 | 137,995 | 547,106 | 140,406 | 149,485 | 161,874 | 142,743 | 594,509 | |||||||||||||||||||||||||||||||||||||||||||||
| — | — | — | — | — | (0 | ) | — | — | — | — | 423 | 356 | 2 | 19 | 800 | |||||||||||||||||||||||||||||||||||||||||||||
| $ | 413,135 | $ | 427,059 | $ | 458,421 | $ | 443,024 | $ | 1,741,639 | $ | 438,910 | $ | 457,930 | $ | 465,208 | $ | 493,744 | $ | 1,855,791 | $ | 472,215 | $ | 491,603 | $ | 519,145 | $ | 469,728 | $ | 1,952,691 | |||||||||||||||||||||||||||||||
| Billing Days: |
64 | 63 | 62 | 64 | 253 | 64 | 63 | 62 | 64 | 253 | 64 | 63 | 66 | 60 | 253 | |||||||||||||||||||||||||||||||||||||||||||||
| Net Sales Per Billing Day: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Physician Business |
$ | 4,444 | $ | 4,775 | $ | 5,309 | $ | 4,892 | $ | 4,852 | $ | 4,785 | $ | 5,082 | $ | 5,266 | $ | 5,559 | $ | 5,173 | $ | 5,178 | $ | 5,425 | $ | 5,413 | $ | 5,449 | $ | 5,365 | ||||||||||||||||||||||||||||||
| Elder Care Business |
2,011 | 2,004 | 2,085 | 2,030 | 2,032 | 2,073 | 2,187 | 2,237 | 2,156 | 2,162 | 2,194 | 2,373 | 2,453 | 2,379 | 2,350 | |||||||||||||||||||||||||||||||||||||||||||||
| — | — | — | — | — | (0 | ) | — | — | — | — | 7 | 6 | — | — | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| $ | 6,455 | $ | 6,779 | $ | 7,394 | $ | 6,922 | $ | 6,884 | $ | 6,858 | $ | 7,269 | $ | 7,503 | $ | 7,715 | $ | 7,335 | $ | 7,378 | $ | 7,803 | $ | 7,866 | $ | 7,829 | $ | 7,718 | |||||||||||||||||||||||||||||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
As of October 2, 2009
SelectTM Net Sales
(in thousands)
| Fiscal 2005 | Fiscal 2006 | Fiscal 2007 | Fiscal 2008 | Fiscal 2009 | |||||||||||
| Consolidated Select Sales |
$ | 137,540 | $ | 157,296 | $ | 185,844 | $ | 234,810 | $ | 281,536 | |||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Segment Information
As of October 2, 2009
(in thousands)
| Three Months Ended | Six Months Ended | |||||||||||
| 10/2/2009 | 9/26/2008 | 10/2/2009 | 9/26/2008 | |||||||||
| NET SALES: |
||||||||||||
| Physician Business |
398,531 | 341,761 | 740,823 | 673,147 | ||||||||
| Elder Care Business |
162,970 | 149,485 | 313,351 | 289,891 | ||||||||
| Corporate Shared Services |
475 | 356 | 1,357 | 779 | ||||||||
| Total net sales |
561,976 | 491,603 | 1,055,530 | 963,817 | ||||||||
| BILLING DAYS: |
68 | 63 | 132 | 127 | ||||||||
| NET SALES PER BILLING DAY: |
||||||||||||
| Physician Business |
5,861 | 5,425 | 5,612 | 5,300 | ||||||||
| Elder Care Business |
2,397 | 2,373 | 2,374 | 2,283 | ||||||||
| Corporate Shared Services |
7 | 6 | 10 | 6 | ||||||||
| Total net sales per billing day |
8,264 | 7,803 | 7,996 | 7,589 | ||||||||
| INCOME FROM OPERATIONS: |
||||||||||||
| Physician Business |
42,546 | 26,164 | 71,264 | 48,373 | ||||||||
| Elder Care Business |
11,631 | 8,399 | 18,755 | 13,853 | ||||||||
| Corporate Shared Services |
(15,543 | ) | (10,157 | ) | (29,736 | ) | (19,789 | ) | ||||
| Total income from operations |
38,635 | 24,405 | 60,284 | 42,436 | ||||||||
| DEPRECIATION: |
||||||||||||
| Physician Business |
1,960 | 1,881 | 3,910 | 3,722 | ||||||||
| Elder Care Business |
1,267 | 1,237 | 2,529 | 2,419 | ||||||||
| Corporate Shared Services |
2,028 | 1,793 | 4,062 | 3,601 | ||||||||
| Total depreciation |
5,256 | 4,912 | 10,501 | 9,742 | ||||||||
| AMORTIZATION OF INTANGIBLE AND OTHER ASSETS: |
||||||||||||
| Physician Business |
574 | 937 | 1,192 | 1,678 | ||||||||
| Elder Care Business |
553 | 594 | 1,086 | 1,175 | ||||||||
| Corporate Shared Services |
62 | 22 | 164 | 44 | ||||||||
| Total amortization of intangible and other assets |
1,190 | 1,553 | 2,442 | 2,897 | ||||||||
| PROVISION FOR DOUBTFUL ACCOUNTS: |
||||||||||||
| Physician Business |
829 | 665 | 1,268 | 1,148 | ||||||||
| Elder Care Business |
422 | 107 | 1,193 | 1,471 | ||||||||
| Total provision for doubtful accounts |
1,250 | 772 | 2,461 | 2,620 | ||||||||
| INTEREST EXPENSE: |
||||||||||||
| Total interest expense |
4,532 | 5,300 | 8,793 | 8,503 | ||||||||
| INTEREST AND INVESTMENT INCOME: |
||||||||||||
| Elder Care Business |
(0 | ) | 10 | 13 | 25 | |||||||
| Corporate Shared Services |
95 | 833 | 216 | 940 | ||||||||
| Total interest and investment income |
95 | 842 | 229 | 964 | ||||||||
| PROVISION (BENEFIT) FOR INCOME TAXES: |
||||||||||||
| Physician Business |
15,459 | 9,117 | 26,085 | 17,676 | ||||||||
| Elder Care Business |
3,564 | 2,327 | 5,529 | 3,704 | ||||||||
| Corporate Shared Services |
(6,058 | ) | (3,340 | ) | (10,437 | ) | (7,090 | ) | ||||
| Total provision for income taxes |
12,964 | 8,104 | 21,177 | 14,291 | ||||||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Current Fiscal Year Balance Sheet
(in thousands)
Consolidated
| As of | ||||||
| 6/26/09 | 10/2/09 | |||||
| ASSETS | ||||||
| Cash |
$ | 129,631 | $ | 130,089 | ||
| Accounts receivable, net |
230,391 | 257,968 | ||||
| Inventory, net |
196,160 | 212,813 | ||||
| Prepaid expenses |
5,190 | 4,262 | ||||
| Other current assets |
27,445 | 32,194 | ||||
| Total current assets |
588,817 | 637,326 | ||||
| Property and equipment, net |
103,552 | 105,499 | ||||
| Goodwill |
114,255 | 115,280 | ||||
| Intangibles, net |
22,442 | 21,604 | ||||
| Other long-term assets |
65,014 | 73,818 | ||||
| Total long-term assets |
305,262 | 316,201 | ||||
| Total assets |
$ | 894,131 | $ | 953,528 | ||
| LIABILITIES & EQUITY | ||||||
| Accounts payable |
$ | 133,781 | $ | 156,966 | ||
| Accrued expenses |
46,196 | 43,248 | ||||
| Revolving line of credit and current portion of long term debt |
50,953 | 50,970 | ||||
| Other current liabilities |
12,882 | 13,653 | ||||
| Total current liabilities |
243,812 | 264,837 | ||||
| Long-term debt |
182,654 | 184,530 | ||||
| Other non-current liabilities |
70,323 | 79,896 | ||||
| Total long-term liabilities |
252,977 | 264,427 | ||||
| Total liabilities |
496,789 | 529,263 | ||||
| Total equity |
397,342 | 424,265 | ||||
| Total liabilities & equity |
$ | 894,131 | $ | 953,528 | ||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Balance Sheet Trend
(in thousands)
Consolidated
|
Fiscal 2007 |
Fiscal 2008 | Fiscal 2009 | ||||||||||||||||||||||
| ASSETS | Jun-06 | Sep-06 | Dec-06 | Mar-07 | Jun-07 | Sep-07 | Dec-07 | Mar-08 | Jun-08 | Sep-08 | Dec-08 | Mar-09 | ||||||||||||
| Cash |
27,784 | 45,676 | 54,904 | 46,658 | 23,954 | 17,041 | 15,031 | 21,122 | 29,840 | 226,055 | 214,709 | 82,031 | ||||||||||||
| Investment in available for sale securities |
— | — | — | — | — | — | — | — | — | — | — | 10,592 | ||||||||||||
| Accounts receivable, net |
206,405 | 225,538 | 219,822 | 222,776 | 222,699 | 232,282 | 224,282 | 237,248 | 227,661 | 240,806 | 232,894 | 230,361 | ||||||||||||
| Inventory, net |
170,612 | 172,127 | 186,193 | 174,130 | 187,499 | 188,087 | 214,256 | 190,846 | 192,707 | 199,337 | 239,940 | 207,593 | ||||||||||||
| Deferred tax assets |
11,181 | 9,042 | 2,128 | 8,776 | 8,987 | 9,319 | 9,175 | 8,183 | 6,805 | — | — | 8,059 | ||||||||||||
| Other current assets |
32,876 | 39,289 | 37,330 | 34,436 | 34,347 | 27,894 | 31,658 | 48,744 | 26,157 | 22,163 | 23,229 | 23,819 | ||||||||||||
| Total current assets |
448,857 | 491,672 | 500,376 | 486,776 | 477,486 | 474,623 | 494,403 | 506,142 | 483,170 | 688,361 | 710,772 | 562,456 | ||||||||||||
|
Property and equipment, net |
88,977 | 88,089 | 86,720 | 89,498 | 90,213 | 90,208 | 90,781 | 91,584 | 92,803 | 96,849 | 97,113 | 101,205 | ||||||||||||
| Goodwill |
106,519 | 106,819 | 106,972 | 107,366 | 110,993 | 110,727 | 110,868 | 110,679 | 112,320 | 112,392 | 112,717 | 112,768 | ||||||||||||
| Intangibles, net |
33,350 | 32,343 | 31,186 | 29,758 | 30,280 | 28,991 | 27,669 | 26,305 | 25,738 | 24,345 | 23,102 | 22,958 | ||||||||||||
| Investment in available for sale securities |
— | — | — | — | 24,232 | 46,147 | 50,206 | 11,318 | 14,231 | 16,725 | 15,333 | — | ||||||||||||
| Other long-term assets |
54,444 | 54,455 | 57,631 | 59,898 | 69,481 | 67,195 | 67,921 | 67,209 | 67,598 | 83,055 | 70,549 | 59,238 | ||||||||||||
| Total long-term assets |
283,291 | 281,706 | 282,509 | 286,521 | 325,198 | 343,268 | 347,446 | 307,094 | 312,690 | 333,365 | 318,815 | 296,169 | ||||||||||||
| Total assets |
732,148 |
773,378 | 782,885 | 773,297 | 802,685 | 817,891 | 841,849 | 813,236 | 795,860 | 1,021,726 | 1,029,587 | 858,624 | ||||||||||||
| Fiscal 2007 | Fiscal 2008 | Fiscal 2009 | ||||||||||||||||||||||
| LIABILITIES & EQUITY | Jun-06 | Sep-06 | Dec-06 | Mar-07 | Jun-07 | Sep-07 | Dec-07 | Mar-08 | Jun-08 | Sep-08 | Dec-08 | Mar-09 | ||||||||||||
| Accounts payable |
122,449 | 145,767 | 162,338 | 131,330 | 144,572 | 149,827 | 161,728 | 135,930 | 128,656 | 149,674 | 155,133 | 127,300 | ||||||||||||
| Accrued expenses |
27,748 | 34,827 | 31,670 | 37,224 | 33,190 | 33,275 | 34,350 | 46,056 | 38,055 | 50,816 | 43,170 | 52,718 | ||||||||||||
| Current maturities of long-term debt |
517 | 1,655 | 138,334 | 2,238 | 2,132 | 32,129 | 33,660 | 214,732 | 196,116 | 198,022 | 199,606 | 50,937 | ||||||||||||
| Deferred tax liabilities, current |
— | — | — | — | — | — | — | — | — | 6,619 | 4,492 | — | ||||||||||||
| Other current liabilities |
12,490 | 13,917 | 10,731 | 11,440 | 15,267 | 15,000 | 15,846 | 11,969 | 8,102 | 8,723 | 9,160 | 7,956 | ||||||||||||
| Total current liabilities |
163,204 | 196,166 | 343,072 | 182,232 | 195,161 | 230,230 | 245,584 | 408,687 | 370,928 | 413,855 | 411,560 | 238,910 | ||||||||||||
|
Long-term debt |
134,053 | 135,358 | 460 | 138,318 | 139,657 | 141,091 | 143,020 | 725 | 706 | 177,650 | 179,395 | 180,965 | ||||||||||||
| Other long-term liabilities |
60,689 | 63,702 | 62,457 | 63,922 | 70,413 | 68,190 | 69,976 | 64,473 | 68,975 | 64,763 | 56,503 | 60,719 | ||||||||||||
| Total long-term liabilities |
194,742 | 199,060 | 62,917 | 202,240 | 210,070 | 209,282 | 212,996 | 65,198 | 69,682 | 242,413 | 235,899 | 241,685 | ||||||||||||
|
Total liabilities |
357,946 | 395,226 | 405,989 | 384,472 | 405,231 | 439,512 | 458,580 | 473,885 | 440,610 | 656,268 | 647,459 | 480,594 | ||||||||||||
| Total equity |
374,202 | 378,152 | 376,896 | 388,824 | 397,454 | 378,379 | 383,269 | 339,351 | 355,250 | 365,458 | 382,127 | 378,030 | ||||||||||||
|
Total liabilities & equity |
732,148 | 773,378 | 782,885 | 773,297 | 802,685 | 817,891 | 841,849 | 813,236 | 795,860 | 1,021,726 | 1,029,587 | 858,624 | ||||||||||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Unaudited Operating Highlights
Current Fiscal Year
(in millions)
| Three Months Ended | Six Months Ended | |||||||||||||||
| Oct. 2, 2009 | Sept. 26, 2008 | Oct. 2, 2009 | Sept. 26, 2008 | |||||||||||||
| Net sales: |
||||||||||||||||
| Physician Business |
$ | 398.5 | $ | 341.8 | $ | 740.8 | $ | 673.1 | ||||||||
| Elder Care Business |
163.0 | 149.5 | 313.4 | 289.9 | ||||||||||||
| Corporate Shared Services |
0.5 | 0.4 | 1.4 | — | ||||||||||||
| Total net sales |
$ | 562.0 | $ | 491.6 | $ | 1,055.5 | $ | 963.0 | ||||||||
| Income from operations: |
||||||||||||||||
| Physician Business |
$ | 42.5 | $ | 26.2 | $ | 71.3 | $ | 48.4 | ||||||||
| Elder Care Business |
11.6 | 8.4 | 18.8 | 13.9 | ||||||||||||
| Corporate Shared Services |
(15.5 | ) | (10.2 | ) | (29.7 | ) | (19.8 | ) | ||||||||
| Total income from operations |
$ | 38.6 | $ | 24.4 | $ | 60.3 | $ | 42.4 | ||||||||
| EBITDA (a) |
$ | 32.1 | $ | 31.4 | $ | 77.7 | $ | 56.2 | ||||||||
| Income from operations, as a percentage of net sales |
6.9 | % | 5.0 | % | 5.7 | % | 4.4 | % | ||||||||
| Consolidated Return on Committed Capital (“ROCC”) (b) |
42.5 | % | 27.8 | % | 34.2 | % | 24.0 | % | ||||||||
| Billing Days |
68 | 63 | 132 | 127 | ||||||||||||
| Net Sales Per Billing Day (in thousands): |
||||||||||||||||
| Physician Business |
$ | 5,861 | $ | 5,425 | $ | 5,612 | $ | 5,300 | ||||||||
| Elder Care Business |
2,397 | 2,373 | 2,374 | 2,283 | ||||||||||||
| Corporate Shared Services |
7 | 6 | 10 | — | ||||||||||||
| Total Net Sales Per Billing Day |
$ | 8,264 | $ | 7,803 | $ | 7,996 | $ | 7,583 | ||||||||
| Net Sales Per Billing Day Growth Rate: |
||||||||||||||||
| Physician Business |
8.0 | % | 5.9 | % | ||||||||||||
| Elder Care Business |
1.0 | % | 4.0 | % | ||||||||||||
| Total Net Sales Per Billing Day Growth Rate |
5.9 | % | 5.5 | % | ||||||||||||
| Annualized | ||||||||||||||||
| Oct. 2, 2009 | Sept. 26, 2008 | |||||||||||||||
| DSO (c) |
||||||||||||||||
| Physician Business |
38.9 | 40.8 | ||||||||||||||
| Elder Care Business |
49.0 | 50.1 | ||||||||||||||
| DOH (d) |
||||||||||||||||
| Physician Business |
54.0 | 52.2 | ||||||||||||||
| Elder Care Business |
51.3 | 52.8 | ||||||||||||||
| DIP (e) |
||||||||||||||||
| Physician Business |
40.4 | 40.7 | ||||||||||||||
| Elder Care Business |
22.8 | 28.1 | ||||||||||||||
| Cash Conversion Days (f) |
||||||||||||||||
| Physician Business |
52.5 | 52.2 | ||||||||||||||
| Elder Care Business |
77.6 | 74.8 | ||||||||||||||
| As of | ||||||||||||||||
| Oct. 2, 2009 | Sept. 26, 2008 | |||||||||||||||
| Operational working capital (g) |
$ | 313.8 | $ | 290.5 | ||||||||||||
| Net debt: |
||||||||||||||||
| Bank debt |
$ | 50.0 | $ | 50.0 | ||||||||||||
| Other debt |
$ | 2.3 | $ | 3.4 | ||||||||||||
| Convertible senior notes |
$ | 183.2 | $ | 322.4 | ||||||||||||
| Less: Cash and cash equivalents |
$ | (130.1 | ) | $ | (226.1 | ) | ||||||||||
| Net debt |
$ | 105.4 | $ | 149.7 | ||||||||||||
Numbers may not foot due to rounding differences
PSS WORLD MEDICAL, INC.
Non GAAP Reconciliations
Net income impact of swine flu related product sales
(in millions, except per share data)
| Three Months Ended |
Diluted EPS |
Six Months Ended |
Diluted EPS | |||||||||||
| Oct. 2, 2009 | Oct. 2, 2009 | |||||||||||||
| Net income |
$ | 21.7 | $ | 0.37 | $ | 35.0 | $ | 0.59 | ||||||
| Less: Impact on pre-tax income from swine flu related product sales |
(2.9 | ) | (4.5 | ) | ||||||||||
| Tax impact on swine flu related product sales |
1.1 | 1.7 | ||||||||||||
| Net income adjusted for swine flu related product sales |
$ | 19.9 | $ | 0.33 | $ | 32.2 | $ | 0.54 | ||||||
Net income impact of ASC 470-20 (Formerly FSP APB 14-1)
(in millions, except per share data)
| Three Months Ended |
Diluted EPS |
Three Months Ended |
Diluted EPS | |||||||||||
| Oct. 2, 2009 | Sept. 26, 2008 | |||||||||||||
| Net Income |
$ | 21.7 | $ | 0.37 | $ | 12.4 | $ | 0.20 | ||||||
| Add Back: Impact of ASC 470-20 |
1.9 | 2.5 | ||||||||||||
| Tax impact on ASC 470-20 |
(0.7 | ) | (0.9 | ) | ||||||||||
| Net income adjusted for the impact of ACS 470-20 |
$ | 22.9 | $ | 0.39 | $ | 13.9 | $ | 0.23 | ||||||
| Six Months Ended |
Diluted EPS |
Six Months Ended |
Diluted EPS | |||||||||||
| Oct. 2, 2009 | Sept. 26, 2008 | |||||||||||||
| Net Income |
$ | 35.0 | $ | 0.59 | $ | 21.7 | $ | 0.35 | ||||||
| Add Back: Impact of ASC 470-20 |
3.7 | 4.0 | ||||||||||||
| Tax impact on ASC 470-20 |
(1.4 | ) | (1.5 | ) | ||||||||||
| Net income adjusted for the impact of ACS 470-20 |
$ | 37.3 | $ | 0.63 | $ | 24.2 | $ | 0.39 | ||||||
Numbers may not foot due to rounding differences
PSS WORLD MEDICAL, INC.
Non GAAP Reconciliations
Average daily net income percent change
(in millions)
| For the Three Months Ended | |||||||||||
| October 2, 2009 | September 26, 2008 | Average Daily Net Income |
|||||||||
| Net Income | Average Daily Net Income |
Net Income | Average Daily Net Income |
||||||||
| Percent Change |
|||||||||||
| Total Company |
21.7 | 0.3 | 12.4 | 0.2 | 62.5 | % | |||||
Physician Business daily net sales impact from swine flu related product sales
(in millions)
| For the Three Months Ended | |||||||||||||
| October 2, 2009 | September 26, 2008 | Average Daily Net Sales |
|||||||||||
| Net Sales | Average Daily Net Sales |
Net Sales | Average Daily Net Sales |
||||||||||
| Percent Change |
|||||||||||||
| Physician Business |
398.5 | 5.9 | 341.8 | 5.4 | 8.0 | % | |||||||
| Less: Impact of swine flu related product sales |
(23.2 | ) | (0.4 | ) | — | — | N/A | ||||||
| Physician Business adjusted for swine flu related product sales |
375.3 | 5.5 | 341.8 | 5.4 | 1.8 | % | |||||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Selling Days Calendar FY09-FY11
| FY2009 | FY2010 | FY2011 | Notes | |||||||||||||||||
| Closing Date |
Selling Days |
Closing Date |
Selling Days |
Closing Date |
Selling Days |
|||||||||||||||
| Apr-06 |
20 | Apr-08 | 20 | Apr-10 | 20 | A | ||||||||||||||
| May-06 |
24 | May-08 | 24 | May-10 | 20 | A | ||||||||||||||
| Jun-06 |
20 | Jun-08 | 20 | Jul-10 | 24 | B | ||||||||||||||
| 64 | 64 | 64 | ||||||||||||||||||
| Jul-06 |
19 | Jul-08 | 24 | Jul-10 | 19 | A | ||||||||||||||
| Aug-06 |
25 | Aug-08 | 20 | Aug-10 | 20 | A | ||||||||||||||
| Sep-08 |
19 | Oct-08 | 24 | Oct-10 | 24 | B | ||||||||||||||
| 63 | 68 | 63 | ||||||||||||||||||
| Oct-06 |
25 | Oct-08 | 20 | Oct-10 | 20 | A | ||||||||||||||
| Nov-06 |
18 | Nov-08 | 18 | Nov-10 | 18 | A | ||||||||||||||
| Jan-06 |
23 | Jan-08 | 23 | Dec-10 | 23 | B | ||||||||||||||
| 66 | 61 | 61 | ||||||||||||||||||
| Jan-06 |
20 | Jan-08 | 20 | Jan-11 | 20 | A | ||||||||||||||
| Feb-06 |
20 | Feb-08 | 20 | Feb-11 | 20 | A | ||||||||||||||
| Mar-09 |
20 | Apr-08 | 25 | Apr-11 | 25 | B | ||||||||||||||
| 60 | 65 | 65 | ||||||||||||||||||
| 253 | 258 | 253 | ||||||||||||||||||
| A | Closing date is the last Friday of the month (for non-quarter end months). |
| B | “Selling Days” defines closing date as the Friday closest to month end based on business days only (for quarter end months only). |
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
EBITDA Calculation
Current Fiscal Year
(in thousands)
| Fiscal 2010 | ||||||||
| Q1 | Q2 | |||||||
| Net Income |
$ | 13,304 | $ | 21,686 | ||||
| Plus: Interest expense |
4,261 | 4,532 | ||||||
| Less: Interest and investment income |
(134 | ) | (95 | ) | ||||
| Plus: Provision for income taxes |
8,213 | 12,964 | ||||||
| Plus: Depreciation |
5,245 | 5,256 | ||||||
| Plus: Amortization of intangible assets |
1,252 | 1,190 | ||||||
| EBITDA |
$ | 32,140 | $ | 45,533 | ||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
EBITDA Calculation
(in thousands)
| Fiscal 2007 | Fiscal 2008 | Fiscal 2009 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total FY 2007 |
Q1 | Q2 | Q3 | Q4 | Total FY 2008 |
Q1 | Q2 | Q3 | Q4 | Total FY 2009 |
||||||||||||||||||||||||||||||||||||||||||||||
| Net income |
$ | 10,139 | $ | 11,951 | $ | 10,282 | $ | 14,777 | $ | 47,148 | $ | 7,792 | $ | 13,578 | $ | 13,249 | $ | 18,515 | $ | 53,133 | $ | 9,372 | $ | 12,363 | $ | 15,989 | $ | 13,763 | $ | 51,486 | ||||||||||||||||||||||||||||||
| Plus: Interest expense |
2,691 | 2,635 | 2,642 | 2,631 | 10,597 | 2,764 | 2,956 | 3,247 | 3,529 | 12,495 | 3,203 | 5,300 | 7,409 | 6,247 | 22,159 | |||||||||||||||||||||||||||||||||||||||||||||
| Less: Interest and investment income |
(98 | ) | (282 | ) | (426 | ) | (385 | ) | (1,191 | ) | (528 | ) | (114 | ) | (26 | ) | (23 | ) | (691 | ) | (122 | ) | (842 | ) | (1,034 | ) | (305 | ) | (2,304 | ) | ||||||||||||||||||||||||||||||
| Plus: Provision for income taxes |
6,449 | 7,681 | 5,862 | 7,824 | 27,817 | 5,010 | 8,551 | 8,441 | 12,597 | 34,599 | 6,187 | 8,104 | 10,230 | 7,709 | 32,229 | |||||||||||||||||||||||||||||||||||||||||||||
| Plus: Depreciation |
4,107 | 4,170 | 4,242 | 4,304 | 16,823 | 4,632 | 4,796 | 4,710 | 4,719 | 18,858 | 4,830 | 4,912 | 5,116 | 5,144 | 20,002 | |||||||||||||||||||||||||||||||||||||||||||||
| Plus: Amortization of intangible assets |
1,500 | 1,477 | 1,469 | 1,462 | 5,908 | 1,458 | 1,406 | 1,362 | 1,360 | 5,586 | 1,344 | 1,553 | 1,264 | 1,328 | 5,489 | |||||||||||||||||||||||||||||||||||||||||||||
| EBITDA |
$ | 24,786 | $ | 27,632 | $ | 24,070 | $ | 30,613 | $ | 107,101 | $ | 21,128 | $ | 31,172 | $ | 30,983 | $ | 40,697 | $ | 123,980 | $ | 24,813 | $ | 31,390 | $ | 38,973 | $ | 33,886 | $ | 129,062 | ||||||||||||||||||||||||||||||
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Return on Committed Capital (ROCC)
Current Fiscal Year
(in thousands)
Consolidated
| Fiscal 2010 | ||||||||
| Q1 | Q2 | |||||||
| Quarterly Average Committed Capital (1) |
$ | 378,397 | $ | 378,706 | ||||
| Committed Capital - Current Quarter |
364,619 | 392,792 | ||||||
| Committed Capital - Previous Quarter |
392,174 | 364,619 | ||||||
| Committed Capital - Previous Year End |
||||||||
| Return on Committed Capital - Quarterly (2) |
28.4 | % | 42.5 | % | ||||
| Return: |
||||||||
| Net income |
13,304 | 21,686 | ||||||
| Add: |
||||||||
| Provision for income taxes |
8,213 | 12,964 | ||||||
| Interest expense |
4,261 | 4,532 | ||||||
| Amortization |
1,252 | 1,190 | ||||||
| Interest and investment income |
(134 | ) | (95 | ) | ||||
| $ | 26,895 | $ | 40,277 | |||||
| Committed Capital: |
||||||||
| Total assets |
$ | 894,131 | $ | 953,528 | ||||
| Less assets excluded: |
||||||||
| Cash |
(129,631 | ) | (130,089 | ) | ||||
| Goodwill and intangibles, net |
(136,696 | ) | (136,884 | ) | ||||
| Total liabilities |
(496,792 | ) | (529,263 | ) | ||||
| Plus liabilities excluded: |
||||||||
| Current debt |
50,953 | 50,970 | ||||||
| Long-term debt |
182,654 | 184,530 | ||||||
| $ | 364,619 | $ | 392,792 | |||||
| (1) | Quarterly Average Committed Capital equals the sum of the committed capital of the most recent two quarters, divided by two. |
| (2) | Return on Committed Capital equals Return divided by Committed Capital. Quarterly calculations are annualized. |
Numbers may not foot due to rounding differences
PSS World Medical, Inc.
Return on Committed Capital (ROCC)
(in thousands)
Consolidated
| Fiscal 2007 | Fiscal 2008 | Fiscal 2009 | |||||||||||||||||||||||||||||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total FY 2007 |
Q1 | Q2 | Q3 | Q4 | Total FY 2008 |
Q1 | Q2 | Q3 | Q4 | Total FY 2009 |
|||||||||||||||||||||||||||||||
| Quarterly Average Committed Capital (1) |
332,763 | 334,894 | 326,477 | 334,112 | 359,807 | 384,428 | 400,611 | 401,541 | 390,439 | 381,257 | 394,469 | 401,387 | |||||||||||||||||||||||||||||||||
| Annual Average Committed Capital (2) |
335,832 | 371,150 | 394,438 | ||||||||||||||||||||||||||||||||||||||||||
| Committed Capital - Current Quarter |
339,461 | 330,327 | 322,628 | 345,597 | 374,016 | 394,840 | 406,381 | 396,702 | 384,175 | 378,339 | 410,600 | 392,174 | |||||||||||||||||||||||||||||||||
| Committed Capital - Previous Quarter |
326,066 | 339,461 | 330,327 | 322,628 | 345,597 | 374,016 | 394,840 | 406,381 | 396,702 | 384,175 | 378,339 | 410,600 | |||||||||||||||||||||||||||||||||
| Committed Capital - Current Year End |
345,597 | 396,702 | 392,174 | ||||||||||||||||||||||||||||||||||||||||||
| Committed Capital - Previous Year End |
326,066 | 345,597 | 396,702 | ||||||||||||||||||||||||||||||||||||||||||
| Return on Committed Capital - Quarterly (3) |
24.9 | % | 28.0 | % | 24.3 | % | 31.5 | % | 27.9 | % | 18.3 | % | 27.4 | % | 26.2 | % | 35.8 | % | 27.9 | % | 20.5 | % | 27.8 | % | 34.3 | % | 28.6 | % | 27.9 | % | |||||||||||||||
| Return on Committed Capital - Annual |
|||||||||||||||||||||||||||||||||||||||||||||
| Return: |
|||||||||||||||||||||||||||||||||||||||||||||
| Income from continuing operations before extraordinary loss |
10,139 | 11,951 | 10,282 | 14,777 | 12,911 | 7,792 | 13,578 | 13,249 | 18,515 | 12,911 | 9,372 | 12,363 | 15,989 | 13,763 | 12,911 | ||||||||||||||||||||||||||||||
| Add: |
|||||||||||||||||||||||||||||||||||||||||||||
| Provision for income taxes |
6,449 | 7,681 | 5,862 | 7,824 | 6,957 | 5,010 | 8,551 | 8,441 | 12,597 | 6,957 | 6,187 | 8,104 | 10,230 | 7,709 | 6,957 | ||||||||||||||||||||||||||||||
| Interest expense |
2,688 | 2,635 | 2,642 | 2,631 | 1,467 | 2,764 | 2,956 | 3,247 | 3,529 | 1,467 | 3,203 | 5,300 | 7,409 | 6,247 | 1,467 | ||||||||||||||||||||||||||||||
| Amortization |
1,500 | 1,477 | 1,469 | 1,462 | 1,871 | 1,458 | 1,406 | 1,362 | 1,360 | 1,871 | 1,344 | 1,553 | 1,264 | 1,328 | 1,871 | ||||||||||||||||||||||||||||||
| Interest and investment income |
(98 | ) | (282 | ) | (426 | ) | (385 | ) | (149 | ) | (528 | ) | (114 | ) | (26 | ) | (23 | ) | (149 | ) | (122 | ) | (842 | ) | (1,034 | ) | (305 | ) | (149 | ) | |||||||||||||||
| 20,677 | 23,462 | 19,828 | 26,309 | 23,057 | 16,496 | 26,377 | 26,273 | 35,978 | 23,057 | 19,983 | 26,478 | 33,856 | 28,742 | 23,057 | |||||||||||||||||||||||||||||||
| Committed Capital: |
|||||||||||||||||||||||||||||||||||||||||||||
| Total assets |
732,148 | 773,377 | 782,885 | 773,297 | 773,297 | 802,685 | 817,891 | 841,849 | 813,236 | 813,236 | 795,860 | 1,021,726 | 1,029,586 | 858,624 | 858,624 | ||||||||||||||||||||||||||||||
| Less assets excluded: |
|||||||||||||||||||||||||||||||||||||||||||||
| Cash |
(27,784 | ) | (45,676 | ) | (54,904 | ) | (46,658 | ) | (46,658 | ) | (23,954 | ) | (17,041 | ) | (15,031 | ) | (21,122 | ) | (21,122 | ) | (29,840 | ) | (226,055 | ) | (214,709 | ) | (82,031 | ) | (82,031 | ) | |||||||||||||||
| Goodwill and intangibles, net |
(139,869 | ) | (139,162 | ) | (138,158 | ) | (137,124 | ) | (137,124 | ) | (141,273 | ) | (139,718 | ) | (138,537 | ) | (136,984 | ) | (136,984 | ) | (138,058 | ) | (136,736 | ) | (135,820 | ) | (135,726 | ) | (135,726 | ) | |||||||||||||||
| DTA from sale of imaging business |
(1,658 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | (0 | ) | |||||||||||||||
| Total liabilities |
(357,946 | ) | (395,226 | ) | (405,989 | ) | (384,472 | ) | (384,472 | ) | (405,231 | ) | (439,512 | ) | (458,580 | ) | (473,885 | ) | (473,885 | ) | (440,610 | ) | (656,268 | ) | (647,459 | ) | (480,594 | ) | (480,594 | ) | |||||||||||||||
| Plus liabilities excluded: |
|||||||||||||||||||||||||||||||||||||||||||||
| Current debt |
517 | 1,655 | 138,334 | 2,238 | 2,238 | 2,132 | 32,129 | 33,660 | 214,732 | 214,732 | 196,116 | 198,022 | 199,606 | 50,937 | 50,937 | ||||||||||||||||||||||||||||||
| Long-term debt |
134,053 | 135,358 | 460 | 138,318 | 138,318 | 139,657 | 141,091 | 143,020 | 725 | 725 | 706 | 177,650 | 179,395 | 180,965 | 180,965 | ||||||||||||||||||||||||||||||
| 339,461 | 330,327 | 322,628 | 345,597 | 345,597 | 374,016 | 394,840 | 406,381 | 396,702 | 396,702 | 384,175 | 378,339 | 410,600 | 392,174 | 392,174 | |||||||||||||||||||||||||||||||
| (1) | Quarterly Average Committed Capital equals the sum of the committed capital of the most recent two quarters, divided by two. |
| (2) | Annual Average Committed Capital equals the sum of the committed capital of the most recent two year ends, divided by two. |
| (3) | Return on Committed Capital equals return divided by Committed Capital. Quarterly calculations are annualized. |
Numbers may not foot due to rounding differences
PSS WORLD MEDICAL, INC.
Footnotes
| (a) | EBITDA represents net income plus provision for income taxes, interest expense, depreciation, and amortization of intangible assets, less interest and investment income. Management review EBITDA when evaluating and comparing the performance of each operating segment on a quarterly basis. Management believes EBITDA is an important measure of liquidity. |
| (b) | ROCC equals return divided by average committed capital. Return is annualized for quarterly and year to date calculations. Management review ROCC when evaluating and comparing the performance of each operating segment on a quarterly basis. Management believes ROCC is an important measure of profitability and return. |
| (c) | DSO is average accounts receivable divided by average daily net sales. Average accounts receivable is the sum of accounts receivable, net of the allowance for doubtful accounts, at the beginning and end of the most recent four quarters divided by five. Average daily net sales are net sales for the most recent four quarters divided by 360. |
| (d) | DOH is average inventory divided by average daily cost of goods sold (“COGS”). Average inventory is the sum of inventory at the beginning and end of the most recent four quarters divided by five. Average daily COGS is quarterly COGS for the most recent four quarters divided by 360. |
| (e) | DIP is average accounts payable divided by average daily COGS. Average accounts payable is the sum of accounts payable at the beginning and end of the most recent four quarters divided by five. |
| (f) | Cash Conversion Days is the sum of DSO and DOH less DIP. |
| (g) | Operational working capital equals accounts receivable plus inventory minus accounts payable. |
| (h) | “Swine flu related product sales” represents increased sales in influenza test kits, surgical masks, medical gloves, hand sanitizers and other products related to the swine flu pandemic. |